SPIROCOR Coronary Outcome by Respiratory Stress Examination
NCT ID: NCT01053975
Last Updated: 2010-11-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
1000 participants
OBSERVATIONAL
2010-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject able to perform the guided breathing protocol and comply with study requirements
* Subject is able and agrees to sign the informed consent form
Exclusion Criteria
* Current digoxin therapy
* Subject has severe valvular heart disease
* Subject has congestive heart failure NYHA class III/IV
* Subject has known history of myocardial infarction (ST elevation or non ST elevation)
* Subject had previous coronary revascularization: CABG or PCI
* Subject has pacemaker or ICD that controls sinus
* Morbidly obese subject (BMI ≥ 40)
* Subject has any significant medical condition which, at the investigator's discretion, may interfere with the subject's optimal participation in the study; and
* Subject is currently participating in another investigational product clinical study that the investigator believes may interfere with the outcome of this study
30 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Spirocor
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Christiana Care Health Services
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
William Weintraub, MD
Role: PRINCIPAL_INVESTIGATOR
Christiana Care Health Systems
Ron Waksman, MD
Role: PRINCIPAL_INVESTIGATOR
Medstar Health Research Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cardiovascular Associates
Birmingham, Alabama, United States
University of Alabama at Birmingham
Birmingham, Alabama, United States
Heart Center Research
Huntsville, Alabama, United States
Phoenix Heart, PLLC
Glendale, Arizona, United States
Escondido Cardiology Associates
Escondido, California, United States
South Denver Heart Cardiology Associates
Littleton, Colorado, United States
Christiana Care Health Services
Newark, Delaware, United States
Clearwater Cardiovascular & Interventional Consultants
Clearwater, Florida, United States
Clearwater Cardiovascular & Interventional Consultants
Largo, Florida, United States
Cardiovascular Research Center of South Florida
Miami, Florida, United States
Mount Sinai Medical Center
Miami Beach, Florida, United States
Clearwater Cardiovascular & Interventional Consultants
Safety Harbor, Florida, United States
University Of Iowa Hospital, Lipid Research Clinic
Iowa City, Iowa, United States
Cardiovascular Associates
Louisville, Kentucky, United States
Cardiovascular Specialists of Central Maryland, PA
Columbia, Maryland, United States
Pentucket Medical Associates
Haverhill, Massachusetts, United States
Minneapolis VAMC
Minneapolis, Minnesota, United States
Catholic Medical Center
Manchester, New Hampshire, United States
Cardiovascular Associates of the DE Valley - Cherry Hill
Cherry Hill, New Jersey, United States
Cardiovascular Associates, DE Valley- Elmer
Elmer, New Jersey, United States
Cardiac & Endovascular Associates
Ridgewood, New Jersey, United States
Cardiovascular Associates, DE Valley- Sewell
Sewell, New Jersey, United States
Sanford Cardiology, a division of Pinehurst Medical, Inc.
Sanford, North Carolina, United States
The Linder Center for Research & Education
Cincinnati, Ohio, United States
North Ohio Research Ltd
Elyria, Ohio, United States
Humility of Mary Health Partners dba, St. Elizabeth Health Center
Youngstown, Ohio, United States
Cardiac Diagnostic Associates, PC
York, Pennsylvania, United States
MUSC
Charleston, South Carolina, United States
Cardiovascular Associates of East Texas
Tyler, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CM-102-005
Identifier Type: -
Identifier Source: org_study_id